Background: An Omega-3 Index (O3I; EPA+DHA as a % of erythrocyte total fatty acids) in the desirable range (8%-12%) has been associated with improved heart and brain health.
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INTRODUCTION

53
In 2018, the American Heart Association (AHA) updated its 2002 recommendations beneficially related to other aging-related health conditions also, such as congitive function [11] 75 and brain volume [12] and increased longevity [13, 14] . 76 There is some controversy regarding the effects of fish intake on the O3I. For example, 77 Block et al reported that individuals reporting an intake of at least 2 fish meals per week had an 78 O3I of 5.1% [7] , and Harris et al. found that after 4 months of consuming 2 oily fish meals per 79 week, the mean O3I was 6.1% [15] . On the other hand, Sands et al. reported a mean O3I of 8% 80 in non-supplementing subjects reporting this weekly intake [16] . So, whether a diet including 81 only 2 servings of fish per week would result in a cardioprotective O3I (8%) or not is unclear. 82 To address this question, we conducted two studies. The first was a small but intensive study 83 using standard dietary intake tools to quantify both fish and EPA+DHA intake and then to 84 correlate these with the O3I. The second was conducted in a "real-world" setting to determine supplement-related questions were as follows: "Do you take an omega-3 supplement?" with the 135 responses: "Yes" or "No." If yes, they were asked which kind of supplement: "Fish oil," "Krill 136 oil," "Algal oil," and "Flaxseed oil." The supplements with EPA+DHA (krill, fish, and algal oils; 137 n=1,681) were included in the "EPA+DHA supplement" category, but individuals who reported 138 taking flaxseed oil (n=45) or did not report the kind of supplement (n=75) were excluded from 139 this analysis. In both studies, an O3I kit was used to collect a dried blood spot as previously described 142 [20] . After receipt in the laboratory, capillary column gas chromatography was used with an 143 internal-standard-based, three-point calibration curve to quantify levels of 24 FAs. Blood spots 144 were transferred to a reaction vial. FA methyl esters were generated using boron trifluoride in 145 methanol as a methylation reagent. Samples were heated for 45 min at 100C, extracted into 146 hexane (after the addition of water) and analyzed using a GC2010 Gas Chromatograph 147 (Shimadzu Corporation, Columbia, MD) equipped with a SP2560, 100-m column (Supelco, 148 Bellefonte, PA). FA were identified by comparison with a standard mixture of FA (GLC, 149 Nucheck Prep, Elysian, MN). The O3I (an erythrocyte-specific metric) was calculated from the 150 dried blood spot EPA+DHA value using an equation derived by comparing values in 98 random 151 samples and is expressed as a percent of total FAs. The correlation coefficient between O3I and 152 the dried blood spot EPA+DHA was 0.96 (P<0.0001). The laboratory coefficient of variation for 153 the O3I is <5%. All individual FA, including EPA and DHA, are whole blood levels. 
Statistical Analyses 155
In study 1, demographic characteristics were compared across fish intake groups using 156 chi-squared and one-way ANOVA methods, with p-values also estimated using a resampling approach to ensure robustness due to small sample sizes within each category. Pearson 158 correlations were computed between the O3I and both the frequency of intake (1 question) and 159 the calculated EPA+DHA intake from the dietary recalls, with multiple regression models used 160 to estimate correlations after adjusting for demographic factors (BMI, age, sex, race). In study 2, 161 multiple regression models were used to estimate the adjusted effects of intake frequency and 162 supplementation on blood FA levels, after adjusting for demographic covariates. Seventy-five 163 percent prediction intervals are calculated in order to provide estimates of the range of O3I 164 values based on reported fish consumption, supplement and age, based on a multiple regression 165 model. A significance level of 0.05 and two-sided tests were used for all analyses which were 166 run using R version 3.5 (www.r-project.org).
RESULTS
168
Study 1 (n=28)
169 Demographic characteristics were not significantly different among the five fish intake 170 groups (Table 1) . Overall, the mean age was 32 years and BMI, 24.3 kg/m2. All participants 171 were from the US, 82% were Caucasian, and 75% were female (Table 1) . Based on the 24-hour 172 dietary recall data, the most commonly eaten fish was tuna (32% of fish eaten) followed by salmon (16%), both of which are species known for their high EPA+DHA content. Eight other 174 varieties of fish and shellfish (cod, imitation crab, shrimp, haddock, catfish, swordfish, mussel, 175 sardines) were significant contributors of EPA+DHA (based on providing at least 0.05g 176 EPA+DHA in the meal-not energy adjusted). Estimated overall EPA+DHA intakes were 300 177 mg/d (assuming 2000 kcal intake, Table 1) , ranging from about 34 to 620 mg/day across fish 178 intake categories.
179
The association between the O3I (and whole blood EPA and DHA separately) and both 180 the five fish intake groups and the calorie-adjusted intake of EPA and DHA were significant. For 181 the former comparison, the Pearson correlation coefficients were 0.48 for EPA (p=0.009), 0.59 182 for DHA (p<0.001) and 0.61 for the O3I (p<0.001). There was an estimated 0.6 percentage point 183 increase in the O3I for each additional fish consumption category ( week (salmon and albacore tuna) provided an average of 485 mg EPA+DHA per day, and after 245 months of this regimen, the mean O3I increased from 4% to 6.2% [15] . This observation further 246 underscores the inability of the AHA recommendations to produce an optimal O3I. 247 Therefore, there is a discrepancy between the amount of EPA+DHA provided by current 248 fish intake recommendations (250-500 mg/d) vs. the amount needed by most Americans to reach 249 an O3I of 8% (>800 mg/d, according to our calculations). As Kuller wrote in a commentary on 250 the 2018 AHA fish intake guidelines, "The key public health question is whether the 251 recommended intake of seafood in the US should be [set so as] to reach the same levels of n-3 252 PUFAs in blood as in Japan, about 9% of total FAs in blood versus 4% in the US [26] ." Based on 253 this rationale (and our data), at least 2-3 servings per week of oily fish, rather than "1-2 servings 254 of seafood" [2], should be the recommendation. But even this will not produce an O3I of >8% -255 to achieve that, either adding an EPA+DHA supplement or increasing to 4-5 servings of oily fish 256 per week would be necessary.
Rimm et al. [2] stated that "…there is little additional benefit in risk reduction with a higher 259 intake [than 1-2 servings per week]." This, in our view, does not reflect the current state of the 260 data. Considerable evidence supports the view that higher fish intakes and higher blood levels of 261 omega-3s are associated with significant additional reduction in cardiovascular risk [3, 5, 27, 262 28], in a dose-dependent manner with no plateau at 1-2 servings per week. The biggest reduction 263 in risk may well occur between zero servings and 1-2 servings per week, but to suggest that there 264 is no additional benefit at high intakes and blood levels ignores a substantial body of evidence 265 cited above. We do recognize that public health recommendations must balance what is ideal vs.
266
what is practical for the public, and also must take into consideration other non-nutritional 267 factors, i.e. potentially hazadous components of fish (mercury, PCBs) and the sustainability of 268 the world's fish supply. However, the basis for concluding that there is "no evidence" that higher 269 fish intakes are associated with improved outcomes is obscure at best.
270
Why is an O3I of 8% the desirable level? The O3I was originally presented as a risk 271 factor for cardiac death, which is where the cut-offs for desirable (>8%) and undesirable (<4%)
272
[10] were estimated from the data available prior to 2004. Recently, a meta-analysis from 10 273 prospective cohort studies has confirmed that an 8% O3I was associated with a 35% reduction in 274 risk for fatal CHD compared to an Index of <4% [9, 27] . In another report, a level of 8% or which achieved an O3I of 8% were more likely to see CVD benefits [37] . Thus, there is 288 substantial evidence supporting a target of 8% or more as optimal.
289
Although an O3I of 8% is a reasonable therapeutic target, is it realistic? Can it be 290 achieved with diet alone? Clearly, it can, again based on the Japanese experience. There, the 291 median fish consumption is ~3 fish servings per week, resulting in an estimated 750 -1,000 mg 292 EPA+DHA per day [4, 38] . Interestingly, this intake is similar to the ~835 mg/day calculated 293 above for 3 fish meals + supplementation. The average erythrocyte EPA+DHA levels in Japan 294 range from 6.8 -9.0%, depending on the study and population [4, 38, 39] . So, yes, an O3I >8% 295 is achievable by diet alone. But Japan is fairly unique. In the US the average fish intake is less 296 than 1 serving per week which provides approximately 100 mg EPA+DHA per day [24] ). The 297 average O3I for Americans ranges from 4%-6% [25] . So, short of adopting the Japanese diet (for 298 a lifetime), it appears that taking an EPA+DHA supplement could be an important for achieving 299 a cardioprotective O3I. The O3I calculator (https://omegaquant.com/omega-3-calculator/) is a 300 useful tool to roughly estimate how much more EPA+DHA one needs to eat in order to achieve a 301 desirable O3I level based on their current levels and intake [8] . For example, according to the 302 calculator, a man with an O3I of 4.5% would need an estimated 951 mg EPA+DHA per day to 303 reach 8%. To get ~950 mg EPA+DHA per day, he could start by eating three wild sockeye 304 salmon meals per week (at 974 mg EPA+DHA per 4-oz. serving), which would amount to 417 mg EPA+DHA per day [21] . Then he could add at least 500 mg EPA+DHA per day through the variability. There were also significant strengths with this study, including the large, real-330 world cohort with self-reported dietary intake, the use of an objective FA biomarker of omega-3 331 status, and the inclusion of a well-validated and widely-used dietary intake tool. 332
CONCLUSION
333
The current study again validates the O3I as a useful biomarker of EPA+DHA intake.
334
Reports of higher fish intake corresponded with higher O3I values in a dose-dependent manner.
335
Reported supplementation with EPA+DHA (fish, krill, or algal oils) was associated with an 336 approximately 2 percentage point higher O3I. The current fish intake recommendations (1-2 337 servings of seafood per week) are unlikely to produce a cardioprotective O3I level, but 338 consuming primarily oily fish 3 times or more per week and supplementation may. Despite these 339 strong relationships, individual variability is great, and testing blood levels is the only way to 340 confirm the omega-3 status. O3I for a one-unit change in the characteristic, e.g. for each additional fish meal per week the 511 estimated effect on O3I is 0.6% (or a 0.6 percentage point increase) both before and after 512 adjusting for other characteristics. with betas (95% CIs) as follows: Asia 0.49% (0.26, 0.73%) †, Europe 0.92% (0.40%, 1.45%) †, 520 South America -0.01% (-0.51%, 0.51%), Africa -0.17% (-1.13%, 0.78%), Australia/NZ 0.32% (-521 0.15%, 0.79%), Canada 0.95% (0.29%, 1.61%)* and Unknown 0.05% (-0.68%, 0.76%). 
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